SpinalCyte Issued Canadian Patent for Spinal Disc Tissue Engineering Technology

SpinalCyte was issued Canadian Patent No. 2,641,170, “Methods and Compositions for Repair of Cartilage using an In Vivo Bioreactor."

The technology, which supports tissue engineering, incorporates a synthetic polymer matrix, a natural hydrogel or a synthetic hydrogel to expose fibroblasts to a mechanical strain using intermittent...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0